AnaptysBio, Inc. (ANAB)
45.78
+0.83
(+1.85%)
USD |
NASDAQ |
Dec 11, 16:00
45.70
-0.08
(-0.17%)
Pre-Market: 09:13
AnaptysBio Research and Development Expense (Quarterly): 31.27M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | 5.853M |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| Vanda Pharmaceuticals, Inc. | 22.56M |
| CorMedix, Inc. | 5.098M |
| Verastem, Inc. | 28.99M |